Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03785847
Other study ID # VCS-008
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 20, 2018
Est. completion date September 17, 2019

Study information

Verified date October 2019
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study includes a comprehensive health examination with focus on respiratory health and the TBFV recordings using impedance pneumography (Ventica®) during sleep at night in healthy children.


Description:

Impedance pneumograpy results in healthy children to generate normal values and to stude the effect of age and gender


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 17, 2019
Est. primary completion date September 17, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Months to 71 Months
Eligibility Inclusion Criteria:

- Age 12 months-71 months, both sexes

- Healthy at the time of inclusion

- Signed informed consent

Exclusion Criteria:

- Preterm birth

- Recurrent bronchitis or recurrent hospitalizations because of a respiratory illness

- Nasal congestion, adenotonsillar hypertrophy, signs and symptoms of sleep apnea or sleep disordered breathing

- Acute respiratory infection or hospitalization because of an acute illness within 4 weeks prior to inclusion

- Personal or family history of asthma

- Recurrent wheezing without respiratory infection

- Allergic rhinitis, chronic rhinosinusitis, or other chronic respiratory disorders

- Atopic dermatitis

- Diagnosed allergic sensitization

- Use of asthma rescue or maintenance medication within 4 weeks prior to inclusion

- Any major chronic illness as judged by the investigators

- Implanted or external active medical devices such as pacemakers

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ventica
Impedance pneumography measurement

Locations

Country Name City State
Finland TAYS Allergiakeskus Tampere

Sponsors (2)

Lead Sponsor Collaborator
Tampere University Hospital Revenio Research

Country where clinical trial is conducted

Finland, 

References & Publications (5)

Malmberg LP, Seppä VP, Kotaniemi-Syrjänen A, Malmström K, Kajosaari M, Pelkonen AS, Viik J, Mäkelä MJ. Measurement of tidal breathing flows in infants using impedance pneumography. Eur Respir J. 2017 Feb 15;49(2). pii: 1600926. doi: 10.1183/13993003.00926-2016. Print 2017 Feb. — View Citation

Seppä VP, Hyttinen J, Uitto M, Chrapek W, Viik J. Novel electrode configuration for highly linear impedance pneumography. Biomed Tech (Berl). 2013 Feb;58(1):35-8. doi: 10.1515/bmt-2012-0068. — View Citation

Seppä VP, Hyttinen J, Viik J. A method for suppressing cardiogenic oscillations in impedance pneumography. Physiol Meas. 2011 Mar;32(3):337-45. doi: 10.1088/0967-3334/32/3/005. Epub 2011 Feb 14. — View Citation

Seppä VP, Pelkonen AS, Kotaniemi-Syrjänen A, Mäkelä MJ, Viik J, Malmberg LP. Tidal breathing flow measurement in awake young children by using impedance pneumography. J Appl Physiol (1985). 2013 Dec;115(11):1725-31. doi: 10.1152/japplphysiol.00657.2013. Epub 2013 Oct 3. — View Citation

Seppä VP, Pelkonen AS, Kotaniemi-Syrjänen A, Viik J, Mäkelä MJ, Malmberg LP. Tidal flow variability measured by impedance pneumography relates to childhood asthma risk. Eur Respir J. 2016 Jun;47(6):1687-96. doi: 10.1183/13993003.00989-2015. Epub 2016 Mar 17. Erratum in: Eur Respir J. 2016 Jul;48(1):285. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ventica measurement level of overnight tidal breathing flow volume variation overnight measurement
See also
  Status Clinical Trial Phase
Recruiting NCT03368612 - Comparative Study Between the AirGoTM System and Standard Tests in the Assessment of the Respiratory Function N/A
Recruiting NCT00530491 - Prospective Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With Reduced Pulmonary Capacity N/A
Completed NCT05267067 - Impact of Positive End Maximum Voluntary Ventilation and Dyspnea Index in Patients After Valvular Heart Surgery N/A
Active, not recruiting NCT04170348 - Daily Vitamin D for Sickle-cell Respiratory Complications Phase 2
Recruiting NCT06019949 - Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury N/A
Completed NCT05098808 - Artificial Intelligence in Diagnosing Dysphagia Patients
Enrolling by invitation NCT01727518 - The Austrian LEAD (Lung hEart sociAl boDy) Study N/A
Recruiting NCT03709199 - Long Term Follow up of Children Enrolled in the REDvent Study
Completed NCT01532180 - Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA) N/A
Terminated NCT00464490 - Use of Dexmedetomidine to Facilitate Extubation in Surgical ICU Patients Who Failed Previous Weaning Attempts N/A
Completed NCT00750074 - Slope of the Pressure-Time Waveform Predicts Resistance and Compliance in Mechanically Ventilated Subjects N/A
Completed NCT00202319 - Effectiveness of Sedation Management in an Australian Intensive Care Unit N/A
Completed NCT05270538 - Cardiorespiratory and Acid-basic Imbalance Caused by Use of Mask N/A
Terminated NCT02022072 - Evaluation of Vital Capacity Phase 2
Recruiting NCT05398068 - Effects of Exercise Training on Exercise Capacity and Sleep Quality in Patients With Obesity Hypoventilation Syndrome N/A
Completed NCT03327610 - Selecting the Best Ventilator Hyperinflation Settings N/A
Completed NCT00665405 - Atelectasis During Delivery - Comparing Cesarian (c) -Section and Labor N/A
Completed NCT00004424 - Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy N/A
Completed NCT04647383 - A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 1
Completed NCT01565954 - Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children